BCM
SGTX

Bridgeway Capital Management’s Sigilon Therapeutics, Inc. Common Stock SGTX Stock Holding History

Bridgeway Capital Management’s Portfolio SGTX Stock Details SGTX Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
2023
Q2 		$216K Hold
2023
Q1 		$116K Hold
2022
Q4 		$43.8K Sell
2022
Q3 		$76K Hold
2022
Q2 		$125K Sell
2022
Q1 		$294K Hold
2021
Q4 		$552K Buy